| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |